{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:58:24Z","timestamp":1790459904803,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.contraception.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T22:10:45Z","timestamp":1552342245000},"page":"345-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study"],"prefix":"10.1016","volume":"99","author":[{"given":"Pauline","family":"Bosco-L\u00e9vy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gouverneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Langlade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Miremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2019.02.011_bb0005","series-title":"M\u00e9thode contraceptives: Focus sur les m\u00e9thodes les plus efficaces disponibles","year":"2016"},{"key":"10.1016\/j.contraception.2019.02.011_bb0010","series-title":"Les Fran\u00e7aises et la contraception: premi\u00e8res donn\u00e9es du Barom\u00e8tre sant\u00e9 2016","year":"2017"},{"key":"10.1016\/j.contraception.2019.02.011_bb0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.011_bb0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/17425247.2017.1353972","article-title":"LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years","volume":"14","author":"Nelson","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.contraception.2019.02.011_bb0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11591290-000000000-00000","article-title":"Efficacy and safety of long-acting reversible Contraception","volume":"71","author":"Stoddard","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2019.02.011_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.contraception.2016.10.006","article-title":"The safety of intrauterine devices among young women: a systematic review","volume":"95","author":"Jatlaoui","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.011_bb0035","first-page":"561","article-title":"The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability","volume":"5","author":"Beatty","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.contraception.2019.02.011_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/PPA.S45710","article-title":"Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States","volume":"8","author":"Yoost","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.contraception.2019.02.011_bb0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2019.02.011_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"25","key":"10.1016\/j.contraception.2019.02.011_bb0070","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.contraception.2019.02.011_bb0075","author":"European Medicines Agency"},{"key":"10.1016\/j.contraception.2019.02.011_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: a review of the literature","volume":"15","author":"Mansour","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2019.02.011_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European active surveillance study for intrauterine devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2019.02.011_bb0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","article-title":"Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European active surveillance study on intrauterine devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.02.011_bb0095","unstructured":"Rahib D, Le Guen M, Lydi\u00e9 N. Contraception \u2013 Quatre ans apr\u00e8s la crise de la pilule, les \u00e9volutions se poursuivent [Internet]. Saint-Maurice, France: Sant\u00e9 Publique France; [cited 2019 Jan 7]. (Barom\u00e8tre Sante 2016). Available from:] http:\/\/inpes.santepubliquefrance.fr\/CFESBases\/catalogue\/pdf\/1806.pdf"},{"key":"10.1016\/j.contraception.2019.02.011_bb0100","series-title":"Contraception chez l'homme et chez la femme","year":"2013"},{"key":"10.1016\/j.contraception.2019.02.011_bb0105","first-page":"1","article-title":"Cohort study of psychiatric adverse events following exposure to Levonorgestrel-containing intrauterine devices in UK general practice","author":"Slattery","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2019.02.011_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psyneuen.2017.02.025","article-title":"The levonorgestrel-releasing intrauterine device potentiates stress reactivity","volume":"80","author":"Aleknaviciute","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2019.02.011_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yhbeh.2018.04.008","article-title":"Progesterone and women's anxiety across the menstrual cycle","volume":"102","author":"Reynolds","year":"2018","journal-title":"Horm Behav"},{"key":"10.1016\/j.contraception.2019.02.011_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/IJWH.S6914","article-title":"Long-term safety, efficacy, and patient acceptability of the intrauterine copper T-380A contraceptive device","volume":"2","author":"Kaneshiro","year":"2010","journal-title":"Int J Women's Health"},{"key":"10.1016\/j.contraception.2019.02.011_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/PPA.S3464","article-title":"Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system","volume":"2","author":"Kailasam","year":"2008","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.contraception.2019.02.011_bb0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.contraception.2019.02.011_bb0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Rev Epidemiol Sante Publique"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419300563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:14:11Z","timestamp":1757880851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782419300563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0010782419300563"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2019.02.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}